• DBI 43-50 peptide

DBI 43-50 peptide

Not For Human Use, Lab Use Only.

Cat.#: 301696

Size:

* Buy 1 get 1 free (?) What is TFA?

Special Price 161.90 USD

Availability: 1-2 weeks
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    DBI 43-50 peptide
  • Documents
  • Sequence Shortening
    RPGLLDLK
  • Sequence
    Arg-Pro-Gly-Leu-Leu-Asp-Leu-Lys
  • Length (aa)
    8
  • Peptide Purity (HPLC)
    98.3%
  • Molecular Formula
    C41H74N12O11
  • Molecular Weight
    911.1
  • Source
    Synthetic
  • Form
    Powder
  • Description

    The peptide RPGLLDLK is a synthetic fragment corresponding to residues 43-50 of the octadecaneuropeptide (ODN), which is itself a brain-derived processing product of diazepam-binding inhibitor (DBI). This octapeptide, along with the closely related fragment DRPGLLDLK (DBI 42-50), represents the C-terminal sequence of ODN. Studies involving intrahippocampal injection in rats have demonstrated that RPGLLDLK can induce electroencephalographic alterations characterized by patterns of limbic seizures, including high-frequency activity and synchronized spike-wave discharges. The epileptogenic activity of this peptide fragment is notably antagonized by PK 11195, a selective ligand for a peripheral-type benzodiazepine recognition site linked to the GABAA receptor complex, but is unaffected by antagonists of central benzodiazepine or NMDA-type glutamate receptors.

  • Storage Guidelines
    Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
  • References
    • Patteux C, Foucout L, Bohn P, Dupas G, Leprince J, Tonon MC, Dehouck B, Marsais F, Papamicaël C, Levacher V Solid phase synthesis of a redox delivery system with the aim of targeting peptides into the brain Org Biomol Chem 2006 Mar 7;4(5):817-25
    • Vezzani A, Serafini R, Stasi MA, Samanin R, Ferrarese C. Epileptogenic activity of two peptides derived from diazepam binding inhibitor after intrahippocampal injection in rats. Epilepsia. 1991 Sep-Oct;32(5):597-603. doi: 10.1111/j.1528-1157.1991.tb04698.x. PMID: 1655399.
  • About TFA salt

    Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.

    Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.

    Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.

    In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.

  • Molar Concentration Calculator

  • Dilution Calculator

  • Percent Concentration Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight

Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.

Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.

Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"